GENTAMICIN SULFATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for gentamicin sulfate and what is the scope of patent protection?
Gentamicin sulfate
is the generic ingredient in twelve branded drugs marketed by Schering, Pharmafair, Alpharma Us Pharms, Cosette, Fougera Pharms Inc, Padagis Us, Pharmaderm, Taro, King Pharms, Bristol, Intl Medication, Abbott, Eugia Pharma, Fresenius Kabi Usa, Hikma, Hospira, Kalapharm, Pharm Spec, Solopak, Teva Parenteral, Watson Labs, Wyeth Ayerst, B Braun, Baxter Hlthcare, Pharmacia And Upjohn, Novartis, Akorn, Fera Pharms Llc, Encube, Allergan, Saptalis Pharms, Alcon Pharms Ltd, Bausch And Lomb, Epic Pharma Llc, Paco, and Sandoz, and is included in sixty-two NDAs. Additional information is available in the individual branded drug profile pages.There are fourteen drug master file entries for gentamicin sulfate. Twenty-six suppliers are listed for this compound.
Summary for GENTAMICIN SULFATE
| US Patents: | 0 |
| Tradenames: | 12 |
| Applicants: | 36 |
| NDAs: | 62 |
| Drug Master File Entries: | 14 |
| Finished Product Suppliers / Packagers: | 26 |
| Raw Ingredient (Bulk) Api Vendors: | 87 |
| Clinical Trials: | 13 |
| Patent Applications: | 704 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in GENTAMICIN SULFATE? | GENTAMICIN SULFATE excipients list |
| DailyMed Link: | GENTAMICIN SULFATE at DailyMed |
Recent Clinical Trials for GENTAMICIN SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Oslo University Hospital | Phase 1/Phase 2 |
| University of California, San Diego | Phase 2 |
| Kaiser Permanente | Phase 2 |
Pharmacology for GENTAMICIN SULFATE
| Drug Class | Aminoglycoside Antibacterial |
US Patents and Regulatory Information for GENTAMICIN SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | GENTAMICIN SULFATE | gentamicin sulfate | SOLUTION/DROPS;OPHTHALMIC | 064048-001 | May 11, 1994 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Bristol | BRISTAGEN | gentamicin sulfate | INJECTABLE;INJECTION | 062288-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| B Braun | GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | gentamicin sulfate | INJECTABLE;INJECTION | 062814-009 | Aug 28, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Padagis Us | GENTAMICIN SULFATE | gentamicin sulfate | OINTMENT;TOPICAL | 062351-001 | Feb 18, 1982 | AT | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
